Valenta Pharm JSC   Report issue

For profit Phase 1 Phase 3 Phase 4
Founded: Moscow Russian Federation (1997)
Status: Left NME R&D (2021)

Organization Overview

First Clinical Trial
2010
NCT03154515
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2024

Timeline

NOW
  • Now

Alternative names

Valenta Pharm JSC